Sarepta Therapeutics

thunderstorm road

Pharma

Patient dies after receiving Sarepta's DMD gene therapy Elevidys

The incident brings attention to the safety of AAV-based gene therapies and could spark renewed concerns over the benefit-risk profile of Elevidys.

Angus Liu Mar 18, 2025 10:34am

Sarepta Sarepta Therapeutics

Sarepta's Elevidys blows sales expectations out of the water

Nov 7, 2024 3:43pm

setback chess beat defeat rook break

Pfizer's DMD loss is Sarepta's gain: analysts

Jun 13, 2024 10:58am

stop light green

Italfarmaco wins FDA's blessing for nonsteroidal DMD therapy

Mar 22, 2024 11:05am

Elevidys gains steam amid Sarepta's efforts to widen FDA label

Feb 29, 2024 4:11pm

Sarepta's Elevidys expansion bid gets fast review without adcomm

Feb 16, 2024 11:05am